On May 27, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. announced the removal of COVID-19 vaccination recommendations for healthy children and pregnant women from the Centers for Disease Control and Prevention’s (CDC) immunization schedule. This decision marks a significant shift in U.S. public health policy and has sparked widespread debate among medical professionals, public health officials, and the general public.
In a brief video posted on the social media platform X, Kennedy stated, “As of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule.” He was joined by Dr. Marty Makary, Commissioner of the Food and Drug Administration (FDA), and Dr. Jay Bhattacharya, Director of the National Institutes of Health (NIH), who echoed the sentiment, emphasizing that the decision was based on “common sense and good science.
This move comes despite the CDC’s previous guidance, which recommended annual COVID-19 vaccinations for individuals aged six months and older. The CDC’s Advisory Committee on Immunization Practices (ACIP) had been scheduled to meet in June to discuss fall vaccination recommendations, including potential updates for high-risk groups. However, Kennedy’s unilateral decision has preempted this process, bypassing the traditional advisory mechanism.
Critics of the decision argue that it undermines established scientific consensus and could have detrimental effects on public health. Dr. Tina Tan, President of the Infectious Diseases Society of America, expressed concern, stating, “COVID-19 infection can have extremely serious consequences in pregnant women, resulting in hospitalization, pre-term labor, pre-eclampsia, heart injury, blood clots, hypertension, and kidney damage.” She further added, “Not vaccinating them is sheer madness and will contribute to a significant increase in possible morbidity and mortality.
The decision also raises questions about the future of insurance coverage for COVID-19 vaccinations. Historically, the CDC’s immunization schedule has served as a basis for determining which vaccines are covered by insurance without cost-sharing. With the removal of the COVID-19 vaccine from the recommended schedule for healthy children and pregnant women, there is uncertainty regarding whether insurance providers will continue to cover these vaccinations for these groups.
Supporters of Kennedy’s decision argue that it reflects a more targeted approach to vaccination, focusing on high-risk populations rather than broad mandates. They contend that the decision aligns with practices in other countries that have limited COVID-19 booster recommendations to older adults and individuals with underlying health conditions. FDA Commissioner Dr. Makary noted that many countries have already stopped recommending routine COVID-19 vaccinations for healthy children, suggesting that the U.S. is aligning with global standards.
This policy change is part of a broader reorganization of the Department of Health and Human Services (HHS), which includes significant staff reductions and restructuring of various agencies. Critics argue that these changes could weaken the nation’s ability to respond effectively to public health crises. Senator Patty Murray described the plan as “an absurd suggestion” that “defies common sense,” citing ongoing outbreaks of bird flu, measles, and the fentanyl epidemic.
As of now, the CDC’s website still lists COVID-19 vaccinations for healthy children and pregnant women in its immunization schedule. It remains to be seen how the agency will respond to Kennedy’s decision and whether it will update its guidance to reflect the new policy. The situation continues to evolve, and further developments are expected in the coming days.
The post HHS Secretary Robert F. Kennedy Jr. Removes COVID-19 Vaccine from CDC Schedule for Healthy Children and Pregnant Women first appeared on Trusted and Verified USA News.
